SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Evolution of HIV and Mpox Epidemics
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
Introduction of Speakers Part 1
Comparing Empirical HIV Incidence With UNAIDS Estimated Incidence Declines in Sub-Saharan Africa (ABSTRACT
126)
Oliver Stevens
Imperial College London, London, UK
All-Cause and Cause-Specific Mortality Trends Among Persons With and Without HIV in Rural Tanzania (ABSTRACT
128)
Julie Ambia
University of Bristol, Bristol, UK
Associations of Dolutegravir and the COVID-19 Pandemic on Viral Suppression in South African Adults (ABSTRACT
129)
Haroon Moolla
University of Cape Town, Cape Town, South Africa
Questions and Answers Part 1
Introduction of Speakers Part 2
A Multistage Sampling Approach to Refine HIV Mortality Estimates in KwaZulu-Natal, South Africa (ABSTRACT
130)
Alastair VanHeerden
Human Sciences Research Council, Pretoria, South Africa
Genotypic Characterization of Mpox and a Tale of 2 Co-Circulating Viruses in Uganda (ABSTRACT
131)
Nicholas Bbosa
London School of Hygiene & Tropical Medicine, London, UK
Characterization of Mpox Cases in Uganda: Diversity of the Confirmed Cases (ABSTRACT
132)
Ritah Namusoosa
Ministry of Health Uganda, Kampala, Uganda
Questions and Answers Part 2
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
